Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications assessment therapy changes drug discontinuation among crohns disease patients using
… Effect OPPORTUNITY Our client had a treatment for kidney disease that had been shown to slow kidney function decline … 10 years. Our team had to address database structure changes and treatment gaps between studies. OUR APPROACH We … studies to obtain the long-term historic control of patients receiving standard of care. We adjusted for …
… our clients on projects to research rare diseases, rare disease treatment, and complications and comorbidities of … alveolar proteinosis Autosomal dominant polycystic kidney disease Central precocious puberty disease Cushing's disease Cystic fibrosis Duchenne muscular …
… studies, the highest failure rates were in studies where patients were the respondents and in studies recruited …
… of health technologies to ICER, we have reviewed key changes in assessment processes and topic selections in the past 10 …
… and cost-effectiveness of natalizumab and fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple … This presentation is based on research sponsored by Biogen using the MSBase registry. …
… Identifying Psychosis in Patients with Dementia: Not a Hallucination or Delusion, the … Share on: August 22, 2019 Identifying Psychosis in Patients with Dementia: Not a Hallucination or Delusion, the … prevalence is higher in Parkinson’s and Alzheimer’s disease compared to other types of dementia. Antipsychotics …
… Using RTI Rarity™ to Support Clinical Trial Diversity … Precise Analysis of Social Risk Data The US Food and Drug Administration (FDA) recently released guidance that …
… and projected treatment mix Estimating current and future drug costs Estimating change in disease-related costs Estimating and presenting changes in annual budget impact and health outcomes …
… Health equity is gaining increased interest and traction among pharmaceutical companies, healthcare organizations and … In this webinar, we’ll present the advantages of using robust health equity research methods and introduce … factors driving gaps and disparities in care and outcomes among these populations. Learning Objectives Examine the …
… Medicare Drug Price Negotiation Under the Inflation Reduction Act … Act (IRA) was signed into law in 2022 and includes the Drug Price Negotiation (DPN) program, which will allow … for price negotiation: orphan drugs approved for only one disease or condition, plasma-derived products, and small …